First patient enrolled in South Africa
As enrollment is underway on the DRTB-HDT study with more patients put on the study, we thought this would be the perfect time to release the first issue of our newsletter. The study is progressing well and has reached a few milestones which we are happy to share with you.
The first participant was enrolled on the 31 January 2023. This milestone was reached by the study team at the Isango Lethemba TB Research Unit in Port Elizabeth, South Africa, under the direction of Dr Francesca Conradie. The DRTB-HDT study, which will enroll 330 participants at sites in South Africa, Mozambique, Romania, Moldova, and Georgia, is supported by the Horizon 2020 program of the European Commission.
Three of the six participating trial sites have already been activated and 9 participants enrolled. The three sites are Aurum Tembisa, South Africa, the Isango Lethemba TB Research Unit in Port Elizabeth South Africa, and The Phthisiopneumology Institute (IFP CD), Moldova. Initiation and activation of the additional sites will take place in April.
European Commission Project Review
On the 13th of March, the consortium presented our project in a European Commission Project Review. On the review day, every work package was presented by its work package leading team in a clear and enthusiastic way. The reviewers were happy with the way we presented the consortium and work together. Their feedback is valuable for us in order to move ahead with the project.
MEET CONSORTIUM MEMBERS
Dr Laura Paramo, Sponsor Medical Expert (University Hospital, LMU Munich Division of Infectious Diseases and Tropical Medicine)
Dr Laura Paramo is a medical doctor from Colombia. She completed her medical training and internal medicine residency in her hometown of Bogota. She has worked for three years as an internist at a tertiary-care University Hospital. During her medical studies and working experience, Dr Paramo was especially interested in lung diseases and was involved in clinical research mainly related to infectious diseases.
She moved to Munich in 2022 and is currently working at the Division of Infectious Diseases and Tropical Medicine of the LMU Klinikum, supporting the sponsor medical expert activities for DRTB-HDT, where she is working in a team with significant experience to provide new therapeutic options for Tuberculosis is truly motivating. “Every day I learn new skills that foster my career development..” said Dr Paramo.
Consortium members are encouraged to share articles, activities and events with the Secretariat to be featured in this monthly update newsletter.